Stepwise Approach in Asthma Revisited 2023: Expert Panel Opinion of Turkish Guideline of Asthma Diagnosis and Management Group

Simple item page
dc.contributor.authorSEÇIL KEPIL ÖZDEMIR
dc.contributor.authorGülfem Çelik
dc.contributor.authoromur aydin
dc.contributor.authorEbru Damadoglu
dc.contributor.authorayse baccioglu
dc.contributor.authorSevim Bavbek
dc.contributor.authorDane Ediger
dc.contributor.authorFerda Oner Erkekol
dc.contributor.authorBilun Gemicioglu
dc.contributor.authorRana Işık
dc.contributor.authorAYSE FÜSUN KALPAKLIOGLU
dc.contributor.authorAli Fuat Kalyoncu
dc.contributor.authorGÜL KARAKAYA
dc.contributor.authorMetin KEREN
dc.contributor.authorDilşad Mungan
dc.contributor.authorI.Kivilcim Oguzulgen
dc.contributor.authorFusun Yildiz
dc.contributor.authorInsu Yilmaz
dc.contributor.authorarzu yorgancıoglu
dc.date.accessioned2025-04-14T05:52:01Z
dc.date.available2025-04-14T05:52:01Z
dc.date.issued2023
dc.description.abstractIntroduction of inhaled corticosteroids (ICS) has been the cornerstone of the long-term management of asthma. ICSs either alone or in combination with long-acting beta-2 agonists have been shown to be associated with favorable asthma outcomes. However, asthma con- trol is still reported to be below expectations all around the world. Research in the last decades focusing on the use of ICS/formoterol both as maintenance and as needed (maintenance and reliever therapy approach) showed improved asthma outcomes. As a result of recent developments, Turkish Asthma Guidelines group aimed to revise asthma treatment recommendations. In general, we recommend physi- cians to consider the risk factors for poor asthma outcomes, patients’ compliance and expectations and then to determine “a personalized treatment plan.” Importantly, the use of short-acting beta-2 agonists alone as a symptom reliever in asthma patients not using regular ICS is no longer recommended. In stepwise treatment approach, we primarily recommend to use ICS-based controllers and initiate ICS as soon as possible. We define 2 different treatment tracks in stepwise approaches as maintenance and reliever therapy or fixed-dose therapy and equally recommend each track depending on the patient’s risks as well as decision of physicians in a personalized manner. For both tracks, a strong recommendation was made in favor of using add-on treatments before initiating phenotype-specific treatment in step 5. A strong recommendation was also made in favor of using biologic agents and/or aspirin treatment after desensitization in severe asthma when indicated.
dc.identifier.DOI-ID10.5152/ThoracResPract.2023.23035
dc.identifier.urihttp://hdl.handle.net/20.500.14701/54986
dc.language.isoİngilizce
dc.subjectSolunum Sistemi
dc.subjectSağlık Bilimleri ve Hizmetleri
dc.subjectPediatri
dc.subjectPsikiyatri
dc.titleStepwise Approach in Asthma Revisited 2023: Expert Panel Opinion of Turkish Guideline of Asthma Diagnosis and Management Group

Files

Collections

TR-Dizin Koleksiyonu